Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
about
Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen.Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy.Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
P2860
Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of lineariifoli ...... bitor for human cancer therapy
@en
Identification of lineariifoli ...... itor for human cancer therapy.
@nl
type
label
Identification of lineariifoli ...... bitor for human cancer therapy
@en
Identification of lineariifoli ...... itor for human cancer therapy.
@nl
prefLabel
Identification of lineariifoli ...... bitor for human cancer therapy
@en
Identification of lineariifoli ...... itor for human cancer therapy.
@nl
P2093
P2860
P356
P1476
Identification of lineariifoli ...... bitor for human cancer therapy
@en
P2093
Rajesh Agarwal
Ruiwen Zhang
Sukesh Voruganti
P2860
P304
P356
10.7555/JBR.30.20160018
P577
2016-05-25T00:00:00Z